Pre-Clinical Testing for Devices and Diagnostics

Similar documents
Introduction to the FDA. Historical Context. Changes over Time FDA - BE-200 9/23/2004. Copyright C. S. Tritt, Ph.D. 1

Paths to Market & FDA Product Lifecycle Regulation. Patricia Kaeding Design of Medical Devices University of Minnesota April 14, 2005

MOBILE MEDICAL APPLICATIONS REVIEWING FDA GUIDANCE FOR INDUSTRY USE

The Institutional Review Board (IRB) Manual

Device research sponsors, whether companies or investigators, are held responsible for meeting the same regulations.

3.1. Overall Principal Investigator (PI), who holds the IDE and/or is the Sponsor

Navigating the FDA, and understanding Medical Device Preemption. Special Counsel Foulston Siefkin

The Children s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures Determination of IND/IDE Requirement

Title: Review of Medical Devices Page: 1 of 5 Written by:

Point-of-Care Cell Processing Devices A Manufacturer s Perspective Clinical trials, regulatory compliance, and commercialization.

Molecular Diagnostics: The Shift to Complexity. Molecular Diagnostics Regulation: Where do we go from here? David W Feigal, Jr.

Rocky Mountain Regulatory Affairs Society. Elements of and Maintenance/Remediation of the Design History File (DHF) March 15, 2017

An Introduction to the Worldwide Regulatory Framework for Medical Devices. Elizabeth Malo M.S., Director, Regulatory Affairs

The FDA/CDRH Perspective in the Regulation of Surgical Mesh

Medical Device Accessories: Defining Accessories and Classification Pathway for New Accessory Types. Draft Guidance for Industry and

Experimental Medical Device Studies in Canada

Design Quality. Indu Lakshman

Draft Guidance for Industry, Clinical Laboratories, and FDA Staff. In Vitro Diagnostic Multivariate Index Assays

INVESTIGATIONAL DEVICES & DRUGS. What is an IRB to do?

FDA Regulatory Environment for Wearables, Implantables, and Other Digital Health Devices

Mitigating Medical Device Risk through Human Factors. Christina Mendat, PhD Director, Research & Human Factors

Course Title ID Duration Basic Premium. Biological Evaluation of Medical Devices: A Risk-Based Approach N mins

Is FMT A Drug? Lance Shea, M.S., J.D. Washington Square, Suite Connecticut Ave., NW Washington, DC, D

Supplies and Reagents

fix Menu FDA Pharm 411 Medical Devices Overview of Device Regulations

Biocompatibility: a risk based approach

Copyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited.

Supplies and Reagents

IRB APPLICATION OF FDA REGULATIONS Click for Animation

Combination Products at US FDA

SOFTWARE APPS AS MEDICAL DEVICES. The Regulatory Landscape 2015 WHITE PAPER WHITE PAPER PRODUCED BY MAETRICS

First Global Forum on Medical Devices Bangkok-Thailand, September Regulatory Control of Medical Devices in Tanzania

Draft Guidance for Industry and FDA Staff Premarket Notification [510(k)] Submissions for Medical Devices that Include Antimicrobial Agents

The Convergence of Software in the Medical Device Industry. Joseph Azary

MCW Office of Research Standard Operating Procedure

Bioresearch Monitoring Inspections in Vitro Diagnostics Devices

Research Involving FDA Regulated Devices Policy 606 Version: 1.1 POLICY

An Industry Perspective

The Complete Guide to FDA Design Controls

Standard and Directives on Medical Devices

Regulations governing the application of medical accelerators

Developing a Companion Diagnostics in parallel to a medicinal product Legal and Regulatory requirements in Europe and in the US

Contents. Regulatory Bodies... 13

CDRH Device Approval

By: Clay Anselmo COO, DLLS, Founder Reglera and Terry J. Dagnon M.S., Vice President Regulatory Affairs, DLSS

US FDA: CMC Issues for INDs

ORC Sponsor-Investigator IDE Checklist

FDA: The New Animal Drug Approval Process and Cell Based Products

3/17/2017. Scope. Guidance 218: Cell Based Products for Animal Use. FDA: The New Animal Drug Approval Process and Cell Based Products

Medidée Services SA. Nano-Tera.ch. 05 February 2015 part 8. PMA, 510k, IDE. Pierre-Alain Sommer

ASQ Tappan Zee Section Medical Devices, New Regulations and Standards. 26 th September / V. Fischer / Rev. 01

Inspections, Compliance, Enforcement, and Criminal Investigations

Software in Medical Devices

Initial registration of import products

Left to Our Own Devices Design Control & Risk Management Strategies for Combination Products

The Risk Management + Design Controls Connection: What Device Makers Need to Know

Research: Ethics, Informed Consent, FDA, Off Label Use

How to Get ISO Certified

CMC Strategy Forum Europe 2016

FDA PLANS TO REGULATE TESTS AS DEVICES. August 2010 SPECIAL REPRINT. By Ellen Flannery and Scott Danzis

FDA s Final Rule on Medical Device Data Systems Signals Active Regulation of Data Communication Technologies

Jeff Yuen and Associates, Inc. PO Box 6026 Orange, CA Zenaida Power Regulatory Expertise:

Incorporating FDA Regulatory Thinking into Plans for Medical Devices

FDA identifies this generic type of device as: Absorbable perirectal spacer.

REIMAGINING DRUG DEVELOPMENT:

Medical Devices; Obstetrical and Gynecological Devices; Classification of the Closed Loop

Focus on Cardiac Devices. with

Niccolo Machiavelli (1523)

FDA Regulation of Testing

Ready or Not: The New Medical Device Regulations Are Here!

Please note that these flowcharts and checklists are from the IRB Researcher Manual.

Please note that these flowcharts and checklists are from the IRB Researcher Manual.

GENEESS Guideline. Best Practices for Electronics in Medical Devices. V1.3 October 2016

Investigational New Devices

Regulation of software a medical device

Devices 3/26/2014. Investigational Devices. What is considered a device?

Regulatory Challenges of Combination Products in EU and US. Afternoon seminar, 24 January 2018 by COBIS and IWA Consulting

MEDICAL DEVICE DESIGN Implementing An Approach CONTROL I. Design control in both QSR and ISO 13485:2003 is complicated. Regardless of the complex

GMP, GLP OR ISO 17025: HOW DO THESE APPLY TO OUTSOURCED ANALYTICAL TESTING?

The Device Side of Combination Products

CBER Regulation of Devices for Cell Therapy

U.S. Food and Drug Administration (FDA) Regulatory Pathways for Medical Devices

Office for Human Subject Protection. University of Rochester

Regulatory Issues in Human Subjects Research

The Quality System Regulation

Casey Medina, CSEP 2

Process validation in medical devices

Process validation in medical devices

DRUG DRAFT GUIDELINE FOR REGISTRATION OF MEDICAL DEVICES FOR HUMAN USE IN UGANDA, SEPTEMBER 2009

ELECtro-Medical devices. in trusted hands. sgs is the world s leading

Engineering Nanomedical Systems

Draft Guidance for Industry and Food and Drug Administration Staff

V&V Best Practices. CASSS, CMC Strategy Forum Steven W. Badelt, PhD Managing Partner Suttons Creek, Inc. SUTTONSCREEK.COM

Overview of the FDA Approval Process for TB Diagnostics

Human Research Protection Program Policy

Software Regulation: The Transfusion Medicine Experience

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland

ASEAN Consultative Committee for Standards & Quality. Medical Device Product Working Group. Common Submission Dossier Template

Title: Department: Approved by: Director, Human Research Review and Compliance

De Novo Classification Process (Evaluation of Automatic Class III Designation) Guidance for Industry and Food and Drug Administration Staff

Transcription:

Pre-Clinical Testing for Devices and Diagnostics Larry O. Blankenship Evergreen Research, Inc. April, 2016 1

Many Levels, Many Approaches The requirements differ dramatically by class and category and specific application Start by finding out: Is it a medical device/diagnostic? What are the risks? What s the classification/approval path? THEN Appropriate preclinical testing can be selected April, 2016 2

Is it a medical device? What is the intended use? What is the impact on the user/patient? What are the claims? April, 2016 3

Is it a Medical Device/Diagnostic? "an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part, or accessory which is: recognized in the official National Formulary, or the United States Pharmacopoeia, or any supplement to them, intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or intended to affect the structure or any function of the body of man or other animals, and which does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of any of its primary intended purposes. From: US Federal Food Drug & Cosmetic (FD&C), Section 201(h) April, 2016 4

Is it a medical device? What is the intended use? What is the impact on the user/patient? What are the claims? Examples: Bathroom scale versus ICU scale Laptop PC Apps for smart phones www.fda.gov classifies most everything April, 2016 5

What s the clinical involvement? Does it touch the patient? Where? For how long? In what way? Is it used with multiple patients? Is it used to apply therapy? Is it used to make patient care decisions? April, 2016 6

What are the risks? What happens if it doesn t work correctly? What happens if it isn t used correctly? What happens if it s built from the wrong materials? April, 2016 7

Regs related to Pre-Clinical Testing QSR: 21CFR820 the Quality System Regulation Design Controls GMPs: Good Manufacturing Practices GLPs: Good Laboratory Practices GCPs: Good Clinical Practices ISO 13485: European QSRs/Design Controls/GMPs ISO 14971: Risk Management (FTA, FMEA, etc.) ISO 17025: European GLPs ISO 14155: European GCPs April, 2016 8

What s the classification/approval path? (determines amount & type of testing via Design Controls) Class 1 (exempt): GMPs only, no design controls Registration/listing only, no filing Class 1 (non-exempt): Full QSR, incl. design controls Registration/listing, typically no filing Class 2 (no clinical): Full QSR, incl. design controls 510(k) filing with pre-clinical testing Class 2 (with clinical): Full QSR, incl. design controls 510(k) with pre-clinical and clinical results Class 3: Full QSR (with clinical), incl. design controls PMA with pre-clinical and clinical test results April, 2016 9

Design Controls and V&V Requirements Document(s) Hazard/Risk Assessment(s) (ISO 14971) Trace Matrix Trace Matrix Does it meet spec? Drawings, Specs, Mfg. Instructions, Device Master Record Prototypes Products Does it work? (i.e., is it Safe and Effective? ) April, 2016 10 Diagram from: FDA Design Control Guidance For Medical Device Manufacturers

Verification: Pre-Clinical Testing Guided by the Design Input Testing the Design Output (in final product form) Examples: Function: Does the IV pump deliver 0.1 to 999 ml/hr? Safety: Does detect air in the line, stop & alarm? What about testing during development not on final products, but prototypes? Important to the Design Process, but not Verification April, 2016 11

Biocompatibility & Sterility Examples of special testing requirements for representative finished products/components only Biocompatibility (ISO 10993, FDA G95) Must be tested on processed materials (final parts/products) Sterility Depends on type (ISO and FDA guidelines for each) Terminal sterilization or resterilizable? Steam (aka Autoclave) Ethylene Oxide Radiation (gamma or e-beam) Chemical (glutaraldehyde, hydrogen peroxide, etc.) The sterilization PROCESS must be verified / validated April, 2016 12

April, 2016 13

Validation: Pre-Clinical Guided by the Functional/User Requirements Testing the Product (in final product form) Examples: User training & interface testing (with clinicians) Can be in a laboratory or simulated use environment Includes GUI testing (Graphic User Interface, touch screen) In vitro validation (i.e., lab testing safety/effectiveness) Example: Diagnostic tests on extracted tissue/serum samples In vitro tissue testing (e.g., laser tissue cutting) In vivo testing (e.g., animal lab testing) Note: Must be GLP to be acceptable for FDA submittal April, 2016 14

Documenting the Results The Design History File (DHF) A key requirement of Design Controls A repository of documentation for the design process Contains all design input, output, hazard & risk assessments (incl. FTAs and FMEAs), design reviews, test protocols, test reports, analyses of test reports, conclusions, actions and closure of action items. Key DHF sections (e.g., pre-clinical protocols/reports) will be part of regulatory approval submittals (e.g., 510(k), IDE, PMA) April, 2016 15

How do I know what s needed? Check FDA Guidelines and recognized standards Examples: Heart valves: ISO 5840 + FDA guideline Ultrasonic imaging: Multiple guidelines & standards A guideline may allow an abbreviated 510(k) Ask the FDA or an EU Notified Body Call DICE (Division of Industry & Consumer Education) Request a pre-submittal review Notified bodies for medical devices (examples): BSI (British Standards Institute) DEKRA (The Netherlands) TUV (Germany) NSAI (National Standards Authority of Ireland) April, 2016 16

PLAN AHEAD!! The Most Important Step The information is available from many sources Expert consultants are available to help guide you Qualified test labs and agencies abound Failing plan to is truly planning to fail! The unacceptable situation: After years of work and millions of dollars, to be told by the FDA you need to do or re-do a test that will now delay you by months or years that could have been done in advance. April, 2016 17

Fear not Seem daunting? Not if you plan ahead. Success, not the devil is in the details. Thank You! If I can help, let me know! Larry O. Blankenship lblankenship@evergreenresearch.com April, 2016 18